Search Results - "Bibl, M."

Refine Results
  1. 1
  2. 2
  3. 3

    Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias by BIBL, M, MOLLENHAUER, B, WILTFANG, J, LEWCZUK, P, ESSELMANN, H, WOLF, S, TRENKWALDER, C, OTTO, M, STIENS, G, RÜTHER, E, KORNHUBER, J

    Published in Molecular psychiatry (01-07-2007)
    “…Biomarkers for differential diagnosis of the three most frequent degenerative forms of dementia, Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations by Bibl, M., Mollenhauer, B., Wolf, S., Esselmann, H., Lewczuk, P., Kornhuber, J., Wiltfang, J.

    Published in Journal of Neural Transmission (01-05-2007)
    “…Cerebrospinal fluid (CSF) carboxyterminally truncated amyloid-beta (A beta ) peptides, A beta 1-42 and tau protein were evaluated in 30 patients with…”
    Get full text
    Journal Article
  6. 6

    Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis? by Mollenhauer, B, Bibl, M, Esselmann, H, Steinacker, P, Trenkwalder, C, Wiltfang, J, Otto, M

    Published in Journal of Neural Transmission (01-07-2007)
    “…To evaluate variations in amyloid beta (Abeta) peptide pattern in cerebrospinal fluid (CSF) in neurodegenerative disorders. A recently established quantitative…”
    Get full text
    Journal Article
  7. 7

    CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies by Bibl, M, Mollenhauer, B, Esselmann, H, Lewczuk, P, Trenkwalder, C, Brechlin, P, Rüther, E, Kornhuber, J, Otto, M, Wiltfang, J

    Published in Journal of Neural Transmission (01-11-2006)
    “…Differential diagnosis of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) is often crucial. CSF Tau protein and Amyloid-beta (A beta) peptides…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease by Mollenhauer, B, Bibl, M, Trenkwalder, C, Stiens, G, Cepek, L, Steinacker, P, Ciesielczyk, B, Neubert, K, Wiltfang, J, Kretzschmar, H A, Poser, S, Otto, M

    Published in Journal of Neural Transmission (01-06-2005)
    “…Measuring proteins in cerebrospinal fluid (CSF) has gained wide acceptance for the differential diagnosis of dementia. Some groups have already extended these…”
    Get full text
    Journal Article
  10. 10

    New perspectives in the laboratory diagnosis of dementia by Bibl, M, Wiltfang, J

    Published in Nervenarzt (01-11-2008)
    “…Over the past 10 years, the status of laboratory analysis in dementia has increasingly changed from its use for exclusion diagnoses for secondary causes of…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Stability of amyloid-β peptides in plasma and serum by Bibl, Mirko, Welge, Volker, Esselmann, Hermann, Wiltfang, Jens

    Published in Electrophoresis (01-02-2012)
    “…Plasma amyloid‐β peptide (Aβ) levels have been suggested as a biomarker candidate for detecting incipient AD. Aβ peptides are known to be sensitive to distinct…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloid β peptides by Bibl, Mirko, Esselmann, Hermann, Otto, Markus, Lewczuk, Piotr, Cepek, Lukas, Rüther, Eckart, Kornhuber, Johannes, Wiltfang, Jens

    Published in Electrophoresis (01-09-2004)
    “…A quantitative urea‐based amyloid β (Aβ)‐sodium dodecyl sulfate‐polyacrylamide gel electrophoresis with Western immunoblot (Aβ‐SDS‐PAGE/immunoblot) reveals…”
    Get full text
    Journal Article
  17. 17

    Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides by Bibl, Mirko, Gallus, Marion, Welge, Volker, Lehmann, Sabine, Sparbier, Katrin, Esselmann, Hermann, Wiltfang, Jens

    Published in Proteomics. Clinical applications (01-04-2012)
    “…Purpose Carboxyterminally elongated and aminoterminally truncated Aβ peptides as well as their pyroglutamate and oxidized derivates are major constituents of…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature by Lewczuk, Piotr, Esselmann, Hermann, Bibl, Mirko, Beck, Georg, Maler, Juan Manuel, Otto, Markus, Kornhuber, Johannes, Wiltfang, Jens

    Published in Journal of molecular neuroscience (01-01-2004)
    “…Cerebrospinal fluid (CSF) concentrations of total Tau and Tau phosphorylated at threonine (position 181 [pTau181]) were studied with ELISA in a group of…”
    Get full text
    Journal Article